TGD001 is being developed to offer patients with clotting disorders a faster, safer and more effective treatment than today’s standard of care – saving lives and reducing disability Following the Phase 1 safety study, TargED intends to further develop TGD001 in patients with AIS and iTTP…

VADUZ, Liechtenstein, Dec. 19, 2024 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces…

The strengthened partnership framework will focus on product qualification and manufacturing readiness of Sivers high precision laser arrays for high volume deployment of optical I/O solutions in AI Datacenters. KISTA, Sweden, Dec. 19, 2024 /PRNewswire/ — Sivers Semiconductors AB (STO:…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.